×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Antibe Therapeutics Shares Sink After Arbitration Case Lost
MarketWatch
By Robb M. Stewart Antibe Therapeutics' shares were down sharply after the biotechnology company lost a dispute in arbitration over a...
2 months ago
Closing Bell: Antibe Therapeutics Inc up on Monday (ATE)
The Globe and Mail
In today's trading, Antibe Therapeutics Inc shares closed at $0.29 after opening the day at $0.26. Intraday prices ranged from $0.26 to...
4 days ago
Antibe Announces Appointment of Receiver
Business Wire
TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE) announced that the Company's request for an...
1 month ago
Antibe Therapeutics Shares Down on Clinical Hold on Otenaproxesul by U.S. Regulator
Morningstar
Antibe Therapeutics Shares Down on Clinical Hold on Otenaproxesul by U.S. Regulator ... Antibe Therapeutics shares were sharply lower Monday...
1 month ago
Antibe Therapeutics To Pay Nuance $24M In Licensing Fight
Law360
Canadian company Antibe Therapeutics Inc. said Monday it has lost its dispute in arbitration with Chinese firm Nuance Pharma Ltd. over a...
2 months ago
Is Antibe Therapeutics (TSE:ATE) In A Good Position To Deliver On Growth Plans?
Yahoo Finance
Antibe Therapeutics didn't record any revenue over the last year, indicating that it's an early stage company still developing its business. So...
7 months ago
Antibe Therapeutics Seeks Creditor Protection - TipRanks.com
Tipranks
Antibe Therapeutics, Inc. (Otc) (TSE:ATE) has released an update. Antibe Therapeutics Inc. has announced plans to file for creditor protection under the...
1 month ago
Antibe Announces TSX Delisting Review
Business Wire
TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE) announced that the Toronto Stock Exchange (“TSX”)...
1 month ago
Antibe Therapeutics Drug Otenaproxesul Placed on Clinical Hold by FDA
MarketWatch
By Adriano Marchese Antibe Therapeutics said Monday that the U.S. Food and Drug Administration placed a clinical hold on its nonsteroidal...
1 month ago
Antibe Therapeutics Faces Receivership and Delisting - TipRanks.com
Tipranks
Antibe Therapeutics, Inc. (Otc) (TSE:ATE) has released an update. Antibe Therapeutics Inc. has undergone significant changes, with the appointment of FTI...
1 month ago